MedTrace Logo

Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies

NCT03178942 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 254

Last updated 2019-03-26

Study results available
· View outcomes & findings →

Summary

Study to Evaluate the Therapeutic Equivalence of Permethrin Cream 5%in the Treatment of Scabies.

Conditions

  • Scabies

Interventions

DRUG

Permethrin Cream, 5%

Permethrin Cream 5%

DRUG

Elimite™ Cream (permethrin) 5%

Permethrin Cream 5%

Sponsors & Collaborators

  • Novum Pharmaceutical Research Services

    collaborator INDUSTRY

  • Encube Ethicals Pvt. Ltd.

    lead INDUSTRY

Principal Investigators

  • Pratik Kamani · Encube Ethicals Pvt. Ltd.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2017-11-11
Completion
2017-11-11
FDA Drug
Yes

Countries

  • United States
  • El Salvador
  • Puerto Rico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03178942 on ClinicalTrials.gov